ArticleActa pharmacologica Sinica2024

Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient.

Fu-Jing Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.